R
Richard Cathomas
Researcher at University of Zurich
Publications - 187
Citations - 7040
Richard Cathomas is an academic researcher from University of Zurich. The author has contributed to research in topics: Medicine & Prostate cancer. The author has an hindex of 30, co-authored 159 publications receiving 4769 citations.
Papers
More filters
Journal ArticleDOI
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial
Nicholas D. James,Nicholas D. James,Matthew R. Sydes,Noel W. Clarke,Malcolm David Mason,David P. Dearnaley,Melissa R. Spears,Alastair W. S. Ritchie,Chris Parker,J. Martin Russell,Gerhardt Attard,Johann S. de Bono,William Cross,Robert Jones,George N. Thalmann,Claire Amos,David Matheson,Robin Millman,Mymoona Alzouebi,Sharon Beesley,Alison Birtle,Susannah Brock,Richard Cathomas,Prabir Chakraborti,Simon Chowdhury,Audrey Cook,Tony Elliott,Joanna Gale,Stephanie Gibbs,John Graham,J. Hetherington,Robert Hughes,Robert W. Laing,Fiona McKinna,Duncan McLaren,Joe M. O'Sullivan,Omi Parikh,Clive Peedell,Andrew Protheroe,Angus Robinson,Narayanan Srihari,Rajaguru Srinivasan,John Staffurth,Santhanam Sundar,Shaun Tolan,David Tsang,John Wagstaff,Mahesh K.B. Parmar +47 more
TL;DR: Zoledronic acid showed no evidence of survival improvement and should not be part of standard of care for this population of men, and heterogeneity in treatment effect across prespecified subsets was not found.
Journal ArticleDOI
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
J. Alfred Witjes,H.M. Bruins,Richard Cathomas,Eva Compérat,Nigel C. Cowan,Georgios Gakis,Virginia Hernández,Estefania Linares Espinós,Anja Lorch,Yann Neuzillet,Mathieu Rouanne,George N. Thalmann,Erik Veskimäe,Maria J. Ribal,Antoine G. van der Heijden +14 more
TL;DR: The results of a collaborative multistakeholder consensus project on advanced bladder cancer (BC) have been incorporated in the 2020 guidelines, addressing those areas where it is unlikely that prospective comparative studies will be conducted.
Journal ArticleDOI
Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial
Miklos Pless,Roger Stupp,Roger Stupp,Hans-Beat Ris,Rolf A. Stahel,Walter Weder,Sandra Thierstein,Marie-Aline Gérard,A. Xyrafas,Martin Früh,Richard Cathomas,Alfred Zippelius,Arnaud Roth,Milorad Bijelovic,Adrian F. Ochsenbein,Urs R. Meier,Christoph Mamot,Daniel Rauch,Oliver Gautschi,Daniel Betticher,René O. Mirimanoff,Solange Peters +21 more
TL;DR: It is suggested that one definitive local treatment modality combined with neoadjuvant chemotherapy is adequate to treat resectable stage IIIA/N2 non-small-cell lung cancer.
Journal ArticleDOI
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer
Jörg Beyer,Peter Albers,Renske Altena,Jorge Aparicio,Carsten Bokemeyer,Jonas Busch,Richard Cathomas,Eva Cavallin-Ståhl,Noel W. Clarke,J. Claßen,Gabriella Cohn-Cedermark,Alv A. Dahl,Gedske Daugaard,U. De Giorgi,M. De Santis,M. de Wit,R. de Wit,Klaus-Peter Dieckmann,Martin Fenner,Karim Fizazi,Aude Flechon,Sophie D. Fosså,J. R. Germá Lluch,Jourik A. Gietema,Silke Gillessen,Aleksander Giwercman,J. T. Hartmann,Axel Heidenreich,Marcus Hentrich,Friedemann Honecker,Alan Horwich,Robert Huddart,S. Kliesch,Christian Kollmannsberger,Susanne Krege,M.P. Laguna,Leendert H. J. Looijenga,Anja Lorch,Jean-Pierre Lotz,Frank Mayer,Andrea Necchi,Nicola Nicolai,Janine Nuver,K. Oechsle,Jan Oldenburg,J. W. Oosterhuis,Thomas Powles,E. Rajpert-De Meyts,Oliver Rick,Giovanni Rosti,Roberto Salvioni,Mark Schrader,S. Schweyer,Felix Sedlmayer,Aslam Sohaib,Rainer Souchon,T. Tandstad,C. Winter,C. Wittekind +58 more
TL;DR: The main recommendations and controversies of this meeting are presented, with a particular focus on acute and late toxic effects as well as on survivorship issues.
Journal ArticleDOI
ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up
Friedemann Honecker,Jorge Aparicio,Daniel M. Berney,Jörg Beyer,Carsten Bokemeyer,Richard Cathomas,Noel W. Clarke,Gabriella Cohn-Cedermark,Gedske Daugaard,K-P Dieckmann,Karim Fizazi,Sophie D. Fosså,J R Germa-Lluch,Patrizia Giannatempo,Jourik A. Gietema,Silke Gillessen,Silke Gillessen,Hege Sagstuen Haugnes,Axel Heidenreich,Kari Hemminki,Robert Huddart,Michael A.S. Jewett,Florence Joly,Jakob Lauritsen,Anja Lorch,Andrea Necchi,Nicola Nicolai,Christoph Oing,Jan Oldenburg,D. Ondruš,Alexandros Papachristofilou,Thomas Powles,Aslam Sohaib,Olof Ståhl,T. Tandstad,Guy C. Toner,Alan Horwich +36 more
TL;DR: The aim of the conference was to develop detailed recommendations on topics relating to testicular cancer that are not covered in detail in the current ESMO Clinical Practice Guidelines (CPGs) and where the available level of evidence is insufficient.